gip and glp-1 receptors Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Biology of Incretins: GLP-1 and
Description
More serious gastrointestinal complications, whilst rare, include acute pancreatitis and gallbladder disease (cholecystitis, cholelithiasis)
Like the ADA, the AACE/ACE algorithm recommends intensification from monotherapy to dual therapy and beyond for patients not achieving glycemic goals after 3 months of therapy with a given antihyperglycemic regimen
The relative risk came out to 0.76, with a confidence interval of 0.42 to 1.36
Why choose compounded GLP-1 over brand-name medications for FSA coverage
